[BIO-B] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[BIO-B] Bio-Rad Laboratories, Inc.
Announcement Date
16-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 229.12%
YoY- -58.04%
Quarter Report
BIO-B's Result
BIO-B's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 649,729 638,476 610,820 681,184 632,124 681,110 676,844 -2.68%
PBT 861,620 -2,786,281 491,078 428,392 137,102 -1,500,427 84,829 367.03%
Tax 208,448 -620,795 107,162 78,684 30,845 -338,176 15,867 454.15%
NP 653,172 -2,165,486 383,916 349,708 106,257 -1,162,251 68,962 345.82%
Tax Rate -24.19% - -21.82% -18.37% -22.50% - -18.70% -
Total Cost -3,443 2,803,962 226,904 331,476 525,867 1,843,361 607,882 -
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 100.53 -339.16 62.85 51.34 16.81 -170.64 10.19 358.07%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS 23.37 -76.26 13.46 12.15 3.65 -39.59 2.33 363.13%
EPS Diluted 23.34 -76.26 13.45 12.14 3.64 -39.59 2.32 364.06%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.